Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Estrella Immunopharma Inc (NASDAQ: ESLA) was $2.1 for the day, down -16.33% from the previous closing price of $2.51. In other words, the price has decreased by -$16.33 from its previous closing price. On the day, 0.62 million shares were traded. ESLA stock price reached its highest trading level at $2.4 during the session, while it also had its lowest trading level at $1.95.
Ratios:
Our analysis of ESLA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 58.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.45. For the most recent quarter (mrq), Quick Ratio is recorded 0.16 and its Current Ratio is at 0.16.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESLA now has a Market Capitalization of 77837728 and an Enterprise Value of 76525144.
Stock Price History:
The Beta on a monthly basis for ESLA is 0.52, which has changed by 1.9880953 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, ESLA has reached a high of $3.15, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is 25.45%, while the 200-Day Moving Average is calculated to be 82.18%.
Shares Statistics:
ESLA traded an average of 221.85K shares per day over the past three months and 548760 shares per day over the past ten days. A total of 37.07M shares are outstanding, with a floating share count of 10.35M. Insiders hold about 72.09% of the company’s shares, while institutions hold 2.08% stake in the company. Shares short for ESLA as of 1761868800 were 63002 with a Short Ratio of 0.28, compared to 1759190400 on 26333. Therefore, it implies a Short% of Shares Outstanding of 63002 and a Short% of Float of 0.5700000000000001.
Earnings Estimates
The performance of Estrella Immunopharma Inc (ESLA) in the stock market is under the watchful eye of 1 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.07.
